David A. Siegel Neuro Pace Inc Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Neuro Pace Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 40,200 shares of NPCE stock, worth $394,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,200
Previous 20,900
92.34%
Holding current value
$394,764
Previous $256,000
74.61%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$25.7 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$25.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$22.7 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$13.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$13.4 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $244M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...